首页> 美国卫生研究院文献>Iranian Journal of Public Health >Efficacy of Ezetimibe/Simvastatin (10/10 mg) versus High Dose Statin in Dyslipidemia Patients: A Meta-Analysis of Randomized Controlled Trials

【2h】

Efficacy of Ezetimibe/Simvastatin (10/10 mg) versus High Dose Statin in Dyslipidemia Patients: A Meta-Analysis of Randomized Controlled Trials

机译：依泽替米贝/辛伐他汀（10/10 mg）与高剂量他汀类药物在血脂异常患者中的疗效：一项随机对照试验的荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

The monotherapies of statin and ezetimibe had not successfully achieved their objectives in the management of lipid levels of dyslipidemia patients. We aimed to compare the effects of combined low-dose simvastatin and ezetimibe versus high-dose statin on the lipid-lowering treatment of dyslipidemia patients.

机译：他汀类药物和依折麦布的单一疗法尚未成功实现其在血脂异常患者血脂水平管理中的目标。我们旨在比较小剂量辛伐他汀和依泽替米贝联合大剂量他汀类药物对血脂异常患者降脂治疗的作用。

著录项

期刊名称 Iranian Journal of Public Health
作者
Gaoming YANG; Dengfeng HAN; Jianhua MA; Xiaoning ZHANG;
展开▼
作者单位

展开▼
年(卷),期 2019(48),8
年度 2019
页码 -1
总页数 13
原文格式 PDF
正文语种
中图分类公共卫生工程;
关键词
Ezetimibe; Statin; Cholesterol; Inflammation; Meta-analysis;

机译：依泽替米贝;他汀;胆固醇;炎症;元分析;

相似文献

外文文献
中文文献
专利

1. Efficacy of Ezetimibe/Simvastatin (10/10 mg) Versus High Dose Statin in Dyslipidemia Patients: A Meta-analysis of Randomized Controlled Trials [J] . Gaoming YANG, Dengfeng HAN, Jianhua MA, Iranian journal of public health. . 2019,第8期

机译：依泽替米贝/辛伐他汀（10/10毫克）与高剂量他汀类药物在血脂异常患者中的疗效：一项随机对照试验的荟萃分析
2. Lipid-Altering Efficacy of Ezetimibe/Simvastatin 10/20 mg Compared to Rosuvastatin 10 mg in High-Risk Patients with and without Type 2 Diabetes Mellitus Inadequately Controlled Despite Prior Statin Monotherapy [J] . VaverkovaH., FarnierM., AvernaM., Cardiovascular therapeutics . 2012,第2期

机译：尽管有先前的他汀类药物单一疗法，但无论有无2型糖尿病的高危患者，依泽替米贝/辛伐他汀10/20 mg与瑞舒伐他汀10 mg的脂质改变功效均未得到充分控制
3. Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study. [J] . Farnier M, Averna M, Missault L, International journal of clinical practice . 2009,第4期

机译：在以前的他汀类药物单一疗法不能充分控制的高危高胆固醇血症患者中，依泽替米贝/辛伐他汀10/20 mg与瑞舒伐他汀10 mg的脂质改变功效-IN-CROSS研究。
4. High Dose Vitamin E Supplementation and Mortality: Discussion of the Results of a Meta-analysis of Randomized Controlled Clinical Trial [C] . International Society for Free Radical Research . 2006

机译：高剂量维生素E补充和死亡率：讨论随机对照临床试验的荟萃分析结果
5. Hypotensive resuscitation versus standard fluid resuscitation for the management of trauma patients in hemorrhagic shock: The safety phase of a randomized controlled trial. [D] . Morrison, C. Anne. 2009

机译：低血压复苏与标准液体复苏在失血性休克中对创伤患者的处理：一项随机对照试验的安全性阶段。
6. Efficacy and Tolerability of a Fixed-Dose Combination of Rosuvastatin and Ezetimibe Compared with a Fixed-Dose Combination of Simvastatin and Ezetimibe in Brazilian Patients with Primary Hypercholesterolemia or Mixed Dyslipidemia: A Multicenter Randomized Trial [O] . Antonio Carlos Amedeo Vattimo, Francisco Antonio Helfestein Fonseca, Douglas Costa Morais, 2020

机译：罗苏伐他汀和欧塞蒂米贝的固定剂量组合的疗效和耐受性与司法素和欧洲血管血症患者的辛伐他汀和欧洲血管血症患者的固定剂量组合相比：多中心随机试验
7. Lipid-Altering Efficacy of Ezetimibe/Simvastatin 10/20 mg Compared to Rosuvastatin 10 mg in High-Risk Patients with and without Type 2 Diabetes Mellitus Inadequately Controlled Despite Prior Statin Monotherapy. [O] . Vaverkova H, Farnier M, Averna M, 2012

机译：尽管有以前的他汀类药物单一疗法治疗，但无论有或没有2型糖尿病的高危患者，依泽替米贝/辛伐他汀10/20 mg与瑞舒伐他汀10 mg的脂质改变功效均未得到充分控制。

Efficacy of Ezetimibe/Simvastatin (10/10 mg) versus High Dose Statin in Dyslipidemia Patients: A Meta-Analysis of Randomized Controlled Trials

摘要

著录项

相似文献

相关主题

期刊订阅